KOVEN ANDREW I
Insider CIK 1258673 · POZN President, Chief Business Ofc. · AUXL EVP, CAO, GC and Secretary · KALA Director · NRBO Director · ARLZ President & Chief Business Off
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MTVA MetaVia Inc. | A Award | 2026-06-08 | 2026-06-08 | 17,186 | — | $0 | 21,339 | SEC↗ |
| MTVA MetaVia Inc. | A Award | 2025-06-30 | 2025-07-01 | 28,147 | — | $0 | 45,699 | SEC↗ |
| KALA KALA BIO, Inc. | A Award deriv | 2025-06-15 | 2025-06-17 | 6,850 | — | $0 | 6,850 | SEC↗ |
| KALA KALA BIO, Inc. | A Award | 2025-06-15 | 2025-06-17 | 3,050 | — | $0 | 16,972 | SEC↗ |
| KALA KALA BIO, Inc. | A Award deriv | 2024-06-11 | 2024-06-12 | 3,900 | — | $0 | 3,900 | SEC↗ |
| KALA KALA BIO, Inc. | A Award | 2024-06-11 | 2024-06-12 | 1,750 | — | $0 | 13,922 | SEC↗ |
| NRBO NeuroBo Pharmaceuticals, I | A Award | 2024-06-07 | 2024-06-07 | 5,051 | — | $0 | 17,552 | SEC↗ |
| NRBO NeuroBo Pharmaceuticals, I | A Award | 2023-07-27 | 2023-07-28 | 12,500 | — | $0 | 100,000 | SEC↗ |
| NRBO NeuroBo Pharmaceuticals, I | A Award | 2023-07-27 | 2023-07-28 | 87,500 | — | $0 | 87,500 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2023-06-22 | 2023-06-23 | 10,020 | — | $0 | 10,020 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2023-06-22 | 2023-06-23 | 3,150 | — | $0 | 3,150 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award | 2023-06-22 | 2023-06-23 | 1,400 | — | $0 | 12,172 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award | 2023-06-22 | 2023-06-23 | 7,515 | — | $0 | 10,772 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 1,000 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 518 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 420 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | D To issuer deriv | 2023-05-31 | 2023-06-02 | 259 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award | 2023-05-31 | 2023-06-02 | 2,197 | — | $0 | 3,257 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2022-06-16 | 2022-06-17 | 50,000 | — | $0 | 50,000 | SEC↗ |
| NRBO NeuroBo Pharmaceuticals, I | A Award deriv | 2022-06-09 | 2022-06-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NRBO NeuroBo Pharmaceuticals, I | A Award deriv | 2021-09-02 | 2021-09-03 | 60,000 | — | $0 | 60,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award | 2021-06-17 | 2021-06-21 | 25,000 | — | $0 | 53,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award | 2020-06-25 | 2020-06-29 | 28,000 | — | $0 | 28,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2019-06-05 | 2019-06-07 | 21,000 | — | $0 | 21,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2018-06-12 | 2018-06-14 | 12,960 | — | $0 | 12,960 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | S Sale | 2018-06-04 | 2018-06-06 | 156,573 | $0.37 | $57.9K | 1,183,419 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | S Sale | 2018-05-14 | 2018-05-16 | 13,964 | $0.52 | $7.3K | 1,339,992 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | S Sale | 2018-03-19 | 2018-03-21 | 9,739 | $1.70 | $16.6K | 1,353,956 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2017-09-28 | 2017-10-02 | 25,920 | — | $0 | 25,920 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | S Sale | 2017-06-05 | 2017-06-06 | 161,906 | $1.28 | $207.2K | 1,363,695 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | A Award deriv | 2017-05-11 | 2017-05-12 | 126,158 | — | $0 | 126,158 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | A Award | 2017-05-11 | 2017-05-12 | 109,190 | — | $0 | 1,525,601 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | S Sale | 2017-03-20 | 2017-03-22 | 7,825 | $2.41 | $18.9K | 1,416,411 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | P Buy | 2017-03-15 | 2017-03-17 | 20,000 | $2.55 | $51.0K | 1,424,236 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | F Tax w/h | 2016-06-03 | 2016-06-07 | 206,070 | $3.97 | $818.1K | 1,404,236 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | P Buy | 2016-05-12 | 2016-05-13 | 71,500 | $3.49 | $249.5K | 1,610,306 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | A Award deriv | 2016-03-17 | 2016-03-18 | 52,592 | — | $0 | 52,592 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | A Award | 2016-03-17 | 2016-03-18 | 62,132 | — | $0 | 1,538,806 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | J Other | 2016-02-05 | 2016-02-09 | 1,476,674 | — | $0 | 1,476,674 | SEC↗ |
| POZN POZEN INC /NC | A Award | 2015-06-03 | 2015-06-04 | 1,476,674 | — | $0 | 1,476,674 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | J Other deriv | 2015-01-29 | 2015-01-30 | 28,125 | $36.53 | $1.03M | 0 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | J Other deriv | 2015-01-29 | 2015-01-30 | 125,000 | $36.53 | $4.57M | 0 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | J Other deriv | 2015-01-29 | 2015-01-30 | 40,600 | $36.53 | $1.48M | 0 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | J Other | 2015-01-29 | 2015-01-30 | 38,721 | $36.53 | $1.41M | 0 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | M Exercise deriv | 2014-11-21 | 2014-11-24 | 9,375 | — | $0 | 28,125 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | M Exercise deriv | 2014-11-21 | 2014-11-24 | 125,000 | — | $0 | 125,000 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | M Exercise | 2014-11-21 | 2014-11-24 | 9,375 | $18.30 | $171.6K | 178,404 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | S Sale | 2014-11-21 | 2014-11-24 | 5,308 | $33.44 | $177.5K | 173,096 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | S Sale | 2014-11-21 | 2014-11-24 | 134,375 | $33.43 | $4.49M | 38,721 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | M Exercise | 2014-11-21 | 2014-11-24 | 125,000 | $20.07 | $2.51M | 169,029 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award deriv | 2014-02-18 | 2014-02-20 | 40,600 | — | $0 | 40,600 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award deriv | 2014-02-18 | 2014-02-20 | 24,000 | — | $0 | 24,000 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | F Tax w/h | 2014-02-18 | 2014-02-20 | 623 | $28.30 | $17.6K | 27,729 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2014-02-18 | 2014-02-20 | 16,300 | — | $0 | 44,029 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2014-02-18 | 2014-02-20 | 6,375 | — | $0 | 28,352 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2014-02-18 | 2014-02-28 | 6,375 | — | $0 | 28,352 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2014-02-18 | 2014-03-12 | 16,300 | — | $0 | 44,029 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | F Tax w/h | 2014-02-07 | 2014-02-11 | 911 | $23.68 | $21.6K | 21,977 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | F Tax w/h | 2013-06-21 | 2013-06-25 | 102 | $17.15 | $1.7K | 22,888 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2013-02-07 | 2014-03-12 | 15,200 | — | $0 | 23,900 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award deriv | 2013-02-07 | 2013-02-11 | 37,500 | — | $0 | 37,500 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | F Tax w/h | 2013-02-07 | 2013-02-11 | 910 | $18.30 | $16.7K | 22,990 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2013-02-07 | 2013-02-11 | 7,700 | — | $0 | 8,700 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2013-02-07 | 2013-02-11 | 15,200 | — | $0 | 23,900 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2012-06-21 | 2012-06-25 | 1,000 | — | $0 | 1,000 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award deriv | 2012-02-03 | 2012-02-07 | 250,000 | — | $0 | 250,000 | SEC↗ |